![Charles Osborne](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Charles Osborne
Directeur Financier/CFO chez
POLAREAN IMAGING PLC
Fortune : 10 332 $ au 31/01/2026
Profil
Charles Fremont Osborne is currently Chief Financial Officer & Executive Director at Polarean Imaging Plc since 2021, with employment at the firm starting in 2019.
Formerly, the roles include Vice President-Finance at International Murex Technologies Corp., Chief Financial Officer at SCYNEXIS, Inc. from 2003 to 2015, Chief Financial Officer at Nobex Corp., and Chief Financial Officer & Secretary at Innocrin Pharmaceuticals, Inc. from 2015 to 2019.
Education includes an undergraduate degree from The University of North Carolina at Charlotte, conferred in 1987.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
POLAREAN IMAGING PLC 0,8 % | 31/12/2024 | 9 656 262 ( 0,8 % ) | 10 332 $ | 31/01/2026 |
Postes actifs de Charles Osborne
| Sociétés | Poste | Début |
|---|---|---|
| POLAREAN IMAGING PLC | Directeur Financier/CFO | 29/04/2019 |
Anciens postes connus de Charles Osborne
| Sociétés | Poste | Fin |
|---|---|---|
Innocrin Pharmaceuticals, Inc.
 Innocrin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops oral inhibitors for the treatment of castration-resistant prostate cancer | Directeur Financier/CFO | 01/04/2019 |
| SCYNEXIS, INC. | Directeur Financier/CFO | 30/06/2015 |
International Murex Technologies Corp.
 International Murex Technologies Corp. Medical SpecialtiesHealth Technology Develops medical diagnostic products | Directeur Financier/CFO | - |
Nobex Corp.
 Nobex Corp. Pharmaceuticals: MajorHealth Technology Provides drug delivery to pharmaceutical industry | Directeur Financier/CFO | - |
Formation de Charles Osborne
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
52
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
International Murex Technologies Corp.
International Murex Technologies Corp. Medical SpecialtiesHealth Technology Develops medical diagnostic products | Health Technology |
SCYNEXIS, Inc.
 SCYNEXIS, Inc. Pharmaceuticals: MajorHealth Technology Develops novel oral and intravenous triterpenoid antifungal for the treatment of several serious fungal infections | Health Technology |
Nobex Corp.
Nobex Corp. Pharmaceuticals: MajorHealth Technology Provides drug delivery to pharmaceutical industry | Health Technology |
The University of North Carolina at Charlotte
 The University of North Carolina at Charlotte Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Innocrin Pharmaceuticals, Inc.
Innocrin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops oral inhibitors for the treatment of castration-resistant prostate cancer | Health Technology |
Polarean Imaging Plc
 Polarean Imaging Plc Medical SpecialtiesHealth Technology Designs, manufactures and sells noble gas polarizer devices & ancillary instruments | Health Technology |
